Display options
Cite
Nasim A, Hayes P, London N, et al. Vascular surgical society of great britain and ireland: In situ replacement of infected aortic grafts with rifampicin-bonded prostheses . Br J Surg. 1999;86(5):695doi: 10.1046/j.1365-2168.1999.0695a.x.
Nasim, A., Hayes, P., London, N., Barrie, W. W., Bell, P. R., & Naylor, A. R. (1999). Vascular surgical society of great britain and ireland: In situ replacement of infected aortic grafts with rifampicin-bonded prostheses . The British journal of surgery, 86(5), 695. https://doi.org/10.1046/j.1365-2168.1999.0695a.x
Nasim, et al. "Vascular surgical society of great britain and ireland: In situ replacement of infected aortic grafts with rifampicin-bonded prostheses ." The British journal of surgery vol. 86,5 (1999): 695. doi: https://doi.org/10.1046/j.1365-2168.1999.0695a.x
Nasim A, Hayes P, London N, Barrie WW, Bell PR, Naylor AR. Vascular surgical society of great britain and ireland: In situ replacement of infected aortic grafts with rifampicin-bonded prostheses . Br J Surg. 1999 May;86(5):695. doi: 10.1046/j.1365-2168.1999.0695a.x. PMID: 10361201.
Copy Download .nbib Format: NLM
Share it on

Br J Surg. 1999 May;86(5):695. doi: 10.1046/j.1365-2168.1999.0695a.x.

Vascular surgical society of great britain and ireland: In situ replacement of infected aortic grafts with rifampicin-bonded prostheses .

The British journal of surgery

Nasim, Hayes, London, Barrie, Bell, Naylor

Affiliations

  1. Royal Infirmary, Leicester, UK.

PMID: 10361201 DOI: 10.1046/j.1365-2168.1999.0695a.x

Abstract

BACKGROUND: Prosthetic graft infection following abdominal aortic aneurysm (AAA) surgery is life threatening. Treatment options include total graft excision and extra-anatomic bypass or in situ replacement of the graft. The latter option is gaining popularity but the long-term outcome remains uncertain, particularly in light of the increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection. A retrospective study was undertaken to assess the outcome after graft excision and in situ replacement with a rifampicin-bonded prosthesis for the treatment of major aortic graft infection. The prevalence of MRSA and its influence on outcome was also assessed. METHODS: Over 6 years between January 1992 and December 1997, 11 patients (eight men) with major aortic graft infection underwent total graft excision and in situ replacement with a rifampicin-bonded prosthesis. RESULTS: The median age was 66 (range 49-78) years. Four patients presented with haemorrhage from an aortoenteric fistula, three had retroperitoneal abscess, two had graft occlusion, one had a perigraft collection on computed tomography and one presented with a ruptured suprarenal false aneurysm. Organisms were cultured from ten patients. Staphylococcus epidermidis and Streptococcus faecalis were predominant. MRSA was isolated from two patients, both of whom had originally undergone ruptured AAA repair. Two patients died and three suffered non-fatal complications. Two patients died during follow-up, one from suspected ongoing MRSA infection and the other from recurrent graft infection. Seven patients remain alive and clinically free from infection, although two were lost to follow-up at 12 and 15 months. CONCLUSION: The long-term results following total graft excision and in situ replacement with a rifampicin-bonded prosthesis appear to be favourable. MRSA infection seems to be associated with a poor prognosis.

Publication Types